Search Results - "O’Connor, Tracey L."

NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer by Ademuyiwa, Foluso O, Bshara, Wiam, Attwood, Kristopher, Morrison, Carl, Edge, Stephen B, Karpf, Adam R, James, Smith A, Ambrosone, Christine B, O'Connor, Tracey L, Levine, Ellis G, Miliotto, Anthony, Ritter, Erika, Ritter, Gerd, Gnjatic, Sacha, Odunsi, Kunle

“…NY-ESO-1 cancer testis (CT) antigen is an attractive candidate for immunotherapy as a result of its high immunogenicity. The aim of this study was to explore…”
Get full text

Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study by Yao, Song, Sucheston, Lara E, Millen, Amy E, Johnson, Candace S, Trump, Donald L, Nesline, Mary K, Davis, Warren, Hong, Chi-Chen, McCann, Susan E, Hwang, Helena, Kulkarni, Swati, Edge, Stephen B, O'Connor, Tracey L, Ambrosone, Christine B

“…Results from epidemiologic studies on the relationship between vitamin D and breast cancer risk are inconclusive. It is possible that vitamin D may be…”
Get full text

Hospice utilization and end-of-life care in metastatic breast cancer patients at a comprehensive cancer center by O'Connor, Tracey L, Ngamphaiboon, Nuttapong, Groman, Adrienne, Luczkiewicz, Debra L, Kuszczak, Sarah M, Grant, Pei C, Kerr, Christopher W

“…Metastatic breast cancer patients have many options for therapy and may be at risk for late or absent hospice referrals, which make meaningful improvements in…”
Get more information

Associations between Serum 25-Hydroxyvitamin D Levels and Health-Related Quality-of-Life Measures in Patients with Breast Cancer: A Longitudinal Study by Cross, Temara, George, Anthony, Attwood, Kristopher, Zhang, Yali, O'Connor, Tracey L, Barone, Nancy, Hulme, Karen, Ambrosone, Christine B, Yao, Song, Hong, Chi-Chen

“…Recent evidence suggests that vitamin D might lower breast cancer mortality. There is also growing interest in vitamin D's potential association with…”
Get full text

Cancer During Pregnancy: The Oncologist Overview by Hepner, Adriana, Negrini, Daniel, Hase, Eliane Azeka, Exman, Pedro, Testa, Laura, Trinconi, Angela F, Filassi, Jose Roberto, Francisco, Rossana Pulcineli Vieira, Zugaib, Marcelo, O’Connor, Tracey L., Martin, Michael Gary

“…Although a rare and challenging condition, cancer during pregnancy should promptly be identified and treated. Not only standards of care guidelines for the…”
Get full text

Positive effects of acupressure bands combined with relaxation music/instructions on patients most at risk for chemotherapy-induced nausea by Peoples, Anita R., Culakova, Eva, Heckler, Charles E., Shayne, Michelle, O’Connor, Tracey L., Kirshner, Jeffrey J., Bushunow, Peter W., Morrow, Gary R., Roscoe, Joseph A.

“…Purpose Research by our group has shown that acupressure bands are efficacious in reducing chemotherapy-induced nausea (CIN) for breast cancer patients who…”
Get full text

Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx by Gandhi, Shipra, Opyrchal, Mateusz, Grimm, Melissa J, Slomba, Ronald T, Kokolus, Kathleen M, Witkiewicz, Agnieszka, Attwood, Kristopher, Groman, Adrienne, Williams, Lauren, Tarquini, Mary Lynne, Wallace, Paul K, Soh, Kah Teong, Minderman, Hans, Maguire, Orla, O’Connor, Tracey L, Early, Amy P, Levine, Ellis G, Kalinski, Pawel

“…BackgroundPresence of cytotoxic T lymphocytes (CTL) in the tumor microenvironment (TME) predicts the effectiveness of cancer immunotherapies. The ability of…”
Get full text

Delayed Seizure Associated with Paclitaxel‐Cremophor EL in a Patient with Early‐Stage Breast Cancer by O'Connor, Tracey L., Kossoff, Ellen

“…Paclitaxel, a microtubule stabilizer, is an effective agent for treating cancer of the breast, ovary, head and neck, and lung. Because paclitaxel is insoluble…”
Get full text

"Waiting for the Other Shoe to Drop:" Distress and Coping During and After Treatment for Breast Cancer by Waldrop, Deborah P., O'Connor, Tracey L., Trabold, Nicole

“…This study explored distress and coping strategies during and after breast cancer treatment. Open ended interview questions were used to explore stress and…”
Get full text

The caregiver effect on treatment decisions for the elderly by O'Connor, Tracey L

Get full text

Osteonecrosis of The Jaw: Dental Outcomes in Metastatic Breast Cancer Patients Treated With Bisphosphonates With/Without Bevacizumab by Ngamphaiboon, Nuttapong, Frustino, Jennifer L, Kossoff, Ellen B, Sullivan, Maureen A, O'Connor, Tracey L

“…Abstract The etiology, optimal management, and outcome of osteonecrosis of the jaw (ONJ) are not well understood. Because healing after mucosal trauma requires…”
Get full text

Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis by Ngamphaiboon, Nuttapong, O’Connor, Tracey L., Advani, Pooja P., Levine, Ellis G., Kossoff, Ellen B.

“…US Oncology Research Trial 9735 reported that TC improved overall survival when compared to doxorubicin and cyclophosphamide in early-stage breast cancer…”
Get full text

Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer by Jitawatanarat, Potjana, O'Connor, Tracey L, Kossoff, Ellen B, Levine, Ellis G, Chittawatanarat, Kaweesak, Ngamphaiboon, Nuttapong

“…We evaluated the tolerability and cardiac safety of docetaxel, cyclophosphamide, and trastuzumab (TCyH) for the treatment of early-stage human epidermal growth…”
Get full text

Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients by Kossoff, Ellen B., Ngamphaiboon, Nuttapong, Laudico, Thomas J., O’Connor, Tracey L.

“…Ixabepilone 40 mg/m 2 administered on an every 3-week schedule is approved for use in metastatic breast cancer (MBC) as monotherapy, or in combination with…”
Get full text

Correction: NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer by Ademuyiwa, Foluso O., Bshara, Wiam, Attwood, Kristopher, Morrison, Carl, Edge, Stephen B., Ambrosone, Christine B., O’Connor, Tracey L., Levine, Ellis G., Miliotto, Anthony, Ritter, Erika, Ritter, Gerd, Gnjatic, Sacha, Odunsi, Kunle

“…The correct affiliation list is: 1 Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, United States of America, 2 Department of…”
Get full text

Factors affecting the delivery of adjuvant/neoadjuvant chemotherapy in older women with breast cancer by O'Connor, Tracey L, Edge, Stephen B, Kossoff, Ellen B, Groman, Adrienne, Wilding, Gregory E, Ademuyiwa, Foluso O, Levine, Ellis G, Watroba, Nancy, Ngamphaiboon, Nuttapong

“…Abstract Background Recent studies suggest that older women derive similar benefits from adjuvant systemic chemotherapy (AST) as younger women. In older women,…”
Get full text

Access to germline testing and prevalence of somatic mutations in patients with breast cancer from disadvantaged areas: A single-center study by Alharbi, Malak, Roy, Arya Mariam, Krishnan, Jayasree, Patel, Archit, Patel, Riya Jayesh, Kapoor, Ankita, Attwood, Kristopher, Catalfamo, Kayla, Omilian, Angela, Gage-Bouchard, Elizabeth R., Yao, Song, O'Connor, Tracey L., Levine, Ellis Glenn, Gandhi, Shipra

“…e13750 Background: Socioeconomic disparities affect clinical outcomes in several malignancies including breast cancer (BC). The Area Deprivation Index (ADI) is…”
Get full text

Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls by Ji, Jingran, Sun, Can-Lan, Dale, William, Cohen, Harvey Jay, Muss, Hyman B., Magnuson, Allison, O'Connor, Tracey L., Freedman, Rachel A., Katheria, Vani, Armenian, Saro, Sedrak, Mina S.

“…12042 Background: Although breast cancer and breast cancer chemotherapy (chemo) have been linked to accelerated functional decline, it is not well understood…”
Get full text

Potential association of SULT2A1 and ABCG2 variant alleles with increased risk for palbociclib toxicity by Wang, Chong, Hwang, Mary, Paulson, Brandon, Mhandire, Doreen, Ozair, Sadat, O'Connor, Tracey L, Gandhi, Shipra, Attwood, Kristopher M, Hertz, Daniel L, Goey, Andrew Kl

“…This study evaluated associations between and variants in other pharmacogenes ( , , , , ) and the risk for palbociclib-associated toxicities. Two hundred…”
Get more information

Phase IIa study of αDC1 vaccines targeting HER2/HER3 combined with pembrolizumab in patients with asymptomatic brain metastasis from triple negative breast cancer or HER2 + breast cancer by Gandhi, Shipra, Forsyth, Peter A. J., Opyrchal, Mateusz, Ahmed, Kamran A., Attwood, Kristopher, Levine, Ellis Glenn, O'Connor, Tracey L., Early, Amy P., Fenstermaker, Robert Alan, Prasad, Dheerendra, Takabe, Kazuaki, Czerniecki, Brian J., Kalinski, Pawel

“…TPS1112 Background: Brain metastases develop in up to 50% patients (pts) with metastatic triple negative breast cancer (TNBC) and HER2 + BC, constituting an…”
Get full text